Watchlist Price Alert

Hepion Pharmaceuticals In... (HEPA)

NASDAQ: HEPA · Real-Time Price · USD

0.32

0.00 (0.63%)

At close: May 12, 2025, 3:59 PM

0.63% (1D)

Bid	0.32
Market Cap	3.47M
Revenue (ttm)	n/a
Net Income (ttm)	-13.19M
EPS (ttm)	-5367.5
PE Ratio (ttm)	n/a
Forward PE	n/a
Analyst	n/a

Ask	0.32
Volume	3,150,041
Avg. Volume (20D)	4,888,476
Open	0.39
Previous Close	0.32
Day's Range	0.32 - 0.39
52-Week Range	0.11 - 68.00
Beta	1.90

About HEPA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol HEPA

Website n/a

Full Company Profile

Why Price Moved

1 week ago

+20.41%

Hepion Pharmaceuticals shares are trading higher a... Unlock content with Pro Subscription

2 months ago

-39.15%

Hepion Pharmaceuticals shares are trading lower after the company announced a 1-for-50 reverse stock split.

News

9 months ago · benzinga.com

Fatty-Liver Focused Hepion Pharmaceuticals Agrees To Merge With Israel-Based Parkinson's Disease Drug Developer

Monday, Hepion Pharmaceuticals Inc (NASDAQ: HEPA) entered into a definitive merger agreement with Pharma Two B Ltd., a late-clinical stage private Israeli company developing P2B001, a combination prod...

1 year ago · investorplace.com

Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?

Hepion Pharmaceuticals (NASDAQ: HEPA ) stock is diving on Monday after the biopharmaceutical company announced plans to wind down a clinical trial. A press release from the company notes that it is wi...

1 year ago · zacks.com

Wall Street Analysts Think Hepion Pharmaceuticals, Inc. (HEPA) Could Surge 674.09%: Read This Before Placing a Bet

The consensus price target hints at a 674.1% upside potential for Hepion Pharmaceuticals, Inc. (HEPA). While empirical research shows that this sought-after metric is hardly effective, an upward trend...